Cryo-Cell International Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
$0.11next fiscal year
Monitoring Framework
Key Performance Indicators
Consolidated Revenue Quarterly7.7M
Net Income Quarterly47.1K
Processing and Storage Fee Revenue Quarterly7.6M
Watch Items
- Duke University License Agreement ArbitrationTrigger: Final arbitration ruling or settlement agreementAction: Re-evaluate long-term cellular therapy expansion plans, capital allocation, and potential reinstatement of the Celle Corp. spinoff.
- NYSE American Continued Listing ComplianceTrigger: Compliance period deadline of September 9, 2027Action: Monitor execution of the accepted remediation plan to resolve the stockholders' deficit and consecutive net losses.
Research as of 20 Jun 2026